Latest Breaking News On - David mcclung - Page 13 : comparemela.com

BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRock s Cell Therapy to Treat Heart Failure

SUNNYVALE, Calif., Aug. 24, 2022 BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of. | August 24, 2022

United statesDavid mcclungPeter altmanAnne lalucExchange commissionBiocardia incMaryland stem cell research fundGlobenewswire incTherapy heart failure trialMyocardial ischemia trialLooking statementsChief financialNc stock exchangePress releaseElivery bcda us09060u5074

BioCardia, Inc (BCDA) CEO Peter Altman on Q2 2022 Results - Earnings Call Transcript

BioCardia, Inc. (NASDAQ:NASDAQ:BCDA) Q2 2022 Earnings Conference Call August 10, 2022, 04:30 PM ET Company Participants Jules Abraham - IR, CORE IR Peter Altman - President and CEO David.

United statesDavid mcclungKumar rajaPeter altmanKumaraguru rajaJules abrahamMichael okunewitchJames molloyCompany participantsCentre for medicareMinistry of healthAlliance global partnersUniversity of wisconsinMaxim groupBiocardia incEuropean union

BIOCARDIA : REPORTS SECOND QUARTER 2022 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS - Form 8-K

BIOCARDIA REPORTS SECOND QUARTER 2022 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS Sunnyvale, Calif. - August 10, 2022 -BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and. | August 10, 2022

United statesDavid mcclungPeter altmanAnne lalucExchange commission onCompany annual report on formExchange commissionBiocardia incDevice agencyDrug development symposiumUnited states patent officeMedicaid servicesMaryland stem cell research fundUnited states securitiesAutologous cellTherapy heart failure trial

BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022

BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid mcclungAnne lalucBiocardia incMaryland stem cell research fundWall streetTherapy heart failure trialMaryland stem cell researchMyocardial ischemia trialChief financial officer

BioCardia to Host Q2 2022 Financial Results and Corporate

SUNNYVALE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the.

United statesDavid mcclungAnne lalucBiocardia incMaryland stem cell research fundTherapy heart failure trialMaryland stem cell researchMyocardial ischemia trialChief financialNasdaq bcda